This message was sent to ##Email##
|
|
|
|
|
| |
AST
AST’s President, Anil Chandraker, was interviewed on NPR’s “The Point” on February 28. To listen to the recording about kidney transplants, click here.
AST
On March 1, the "Living Donor Protection Act of 2017" was reintroduced to Congress by Congressmen Jerrold Nadler and Congresswoman Jaime Herrera Beutler. Click here for more information.
AST
In memory of former AST President and TIRN co-founder Daniel R. Salomon, the AST has partnered with the Salomon family to create a memorial fund entitled the Frontiers in Transplantation Endowment (FITE), designed to promote transformative science.
READ MORE
 |
|
We are collaborating with the transplant community to improve the health of transplant patients through
• Innovative approaches and partnerships in data generation
• Working to improve long-term graft and patient survival
• Encouraging success through patient programs and outreach
We are committed to you, your patients, and the future of transplantation
|
|
AST
The deadline to submit abstracts for the 2017 Advances in Organ Transplantation is March 12, 2017. For more information, click here.
AST
The Division of Transplantation (DoT) has created an e-news bulletin that touches upon several research programs funded by its grants. To learn more about this bulletin, click here.
AST
Check out AST's archived webinars and journal clubs, and watch educational content when it's convenient for you. The AST also offers a variety of resources for different transplant specialties, all available on our easy-to-search website.
University of Pittsburgh
The Thomas E. Starzl Transplantation Institute is accepting nominations for the 2018 Thomas E. Starzl Prize in Surgery and Immunology, awarded annually to a national or international leader in the field of organ transplantation and immunology.
READ MORE
ATC
The American Transplant Congress (ATC) is coming! Scheduled for April 29- May 3 in Chicago Illinois, ATC is the foremost educational event in the field of basic and clinical transplantation.
Reserve your space and review the preliminary program.
The AJT Report
MIPS includes quality, resource use, advancing care information and clinical practice improvement activities. "MIPS is a continuation of fee-for-service, with a reward/penalty system around value," says Frank Opelka, MD, chair of Surgical Quality Alliance estabilished by the American College of Surgeons (ACS).
READ MORE
American Journal of Transplantation
Although the MELDNa score is now used for liver transplant allocation in the United States, mortality prediction may be underestimated by the score. Using aggregated electronic health record data from 7,834 adult patients with cirrhosis, we determined whether the cause of cirrhosis/cirrhosis complications is associated with an increased risk of death among patients with a MELDNa less than or equal to 15 and whether patients with the greatest risk of death could benefit from liver transplantation (LT).
READ MORE
American Journal of Transplantation
Extending the functional integrity of renal allografts is the primary goal of transplant medicine. Development of donor-specific antibodies (DSAs) post-transplant leads to chronic active antibody-mediated rejection (cABMR) and transplant glomerulopathy (TG), resulting in the majority of graft losses in the U.S. This reduces the quality & length of life for patients and increases cost.
READ MORE
American Journal of Transplantation
Current diagnostic criteria for primary non-function (PNF) of liver grafts are based on clinical experience rather than statistical methods. A retrospective, single center study was conducted of all adults (n=1,286) who underwent primary liver transplant 2000-2008 in our center. Laboratory variable during the first post-liver transplant week were analyzed.
READ MORE
American Journal of Transplantation
We present this observational study of lung transplant recipients (LTR) treated with Carfilzomib (CFZ)-based therapy for antibody-mediated rejection (AMR) of the lung. Patients were considered responders to CFZ if C1q-fixing ability of their immunodominant (ID) DSA was suppressed after treatment. Treatment consisted of CFZ plus plasma exchange and immunoglobulins.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
